As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the pharmaceuticals industry, ...

What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday unveiled that Mulligan made a notable purchase of 101,621 shares of Jazz Pharmaceuticals, valuing at ...

In a precedential ruling, the U.S. Court of Appeals for the Federal Circuit in Jazz Pharma. v. Avadel CNS Pharma., 2025 WL ...

Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) in Q1 CY2025, with sales flat year on year at $897.8 million. On the ...

Biopharma company Jazz Pharmaceuticals (NASDAQ:JAZZ) will be reporting earnings tomorrow afternoon. Here’s what to look for.

Jazz Pharmaceuticals JAZZ will release its quarterly earnings report on Tuesday, 2025-05-06. Here's a brief overview for ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued stocks in the Pharmaceuticals industry for Tuesday, May 13, 2025. Let’s take ...

Avadel Pharmaceuticals gains 1.6% after a favorable court ruling in its narcolepsy drug dispute with Jazz Pharma. See how ...

US biotech Jazz Pharmaceuticals (Nasdaq: JAZZ) is banking on continued growth from Epidiolex (cannabidiol), the first ...

This guidance remains subject to final acquisition accounting. Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the BofA Securities 2025 Healthcare ...

Jazz Pharmaceuticals (NASDAQ:JAZZ) will release its quarterly earnings report on Tuesday, 2025-05-06. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Jazz ...